4570.T
Immuno-Biological Laboratories Co.,Ltd.
グロース · 医薬品 · 医薬品 · JP
JPY 1,047.00
+1.65%Year over year
Reported trailing growth
- Revenue
- +3.6%
- EBITDA
- —
- EBIT
- +34.4%
- EPS
- +32.1%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +2.1%
- EBITDA
- —
- EPS
- -19.5%
Three-year CAGR
- Revenue
- +8.1%
- EBITDA
- +67.8%
- EBIT
- +69.2%
- Net income
- +33.0%
- EPS
- +32.7%
- Free cash flow
- +51.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026